Prediction of restenosis after carotid artery stent implantation.

[1]  Wilfried Lang,et al.  Acute-phase response after stent implantation in the carotid artery: association with 6-month in-stent restenosis. , 2003, Radiology.

[2]  Mary E. Russell,et al.  TAXUS I: Six- and Twelve-Month Results From a Randomized, Double-Blind Trial on a Slow-Release Paclitaxel-Eluting Stent for De Novo Coronary Lesions , 2003, Circulation.

[3]  L. Csiba,et al.  Early-Onset Carotid Atherosclerosis Is Associated With Increased Intima-Media Thickness and Elevated Serum Levels of Inflammatory Markers , 2003, Stroke.

[4]  M. Trip,et al.  Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy. , 2002, Atherosclerosis.

[5]  A. Hofman,et al.  C-Reactive Protein Predicts Progression of Atherosclerosis Measured at Various Sites in the Arterial Tree: The Rotterdam Study , 2002, Stroke.

[6]  D. Faxon.  Systemic drug therapy for restenosis: "déjà vu all over again". , 2002, Circulation.

[7]  P. Serruys,et al.  Intravascular Ultrasound Findings in the Multicenter, Randomized, Double-Blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) Trial , 2002, Circulation.

[8]  O. Wagner,et al.  Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries. , 2002, Radiology.

[9]  Renu Virmani,et al.  Morphological Predictors of Restenosis After Coronary Stenting in Humans , 2002, Circulation.

[10]  P. Serruys,et al.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.

[11]  O. Wagner,et al.  Balloon Angioplasty and Stent Implantation Induce a Vascular Inflammatory Reaction , 2002, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[12]  V. Howard,et al.  Organizing the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): National Institutes of Health, Health Care Financing Administration, and industry funding , 2001, Current controlled trials in cardiovascular medicine.

[13]  M. Hori,et al.  C-Reactive Protein Is an Independent Predictor of the Rate of Increase in Early Carotid Atherosclerosis , 2001, Circulation.

[14]  M. Eliasziw,et al.  Endarterectomy or angioplasty for treatment of carotid stenosis? , 2001, The Lancet.

[15]  J M Bland,et al.  Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial , 2001, The Lancet.

[16]  M. Di Napoli,et al.  C-Reactive Protein in Ischemic Stroke: An Independent Prognostic Factor , 2001, Stroke.

[17]  P. O'Malley,et al.  Design and rationale of the ARBITER trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)--a randomized trial comparing the effects of atorvastatin and pravastatin on carotid artery intima-media thickness. , 2001, American heart journal.

[18]  S S Iyer,et al.  Immediate and Late Clinical Outcomes of Carotid Artery Stenting in Patients With Symptomatic and Asymptomatic Carotid Artery Stenosis: A 5-Year Prospective Analysis , 2001, Circulation.

[19]  D. Sackett,et al.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. , 1991, The New England journal of medicine.

[20]  B. Young,et al.  C‐Reactive Protein: A Critical Review , 1991, Pathology.